These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25982517)

  • 1. Treating acute pancreatitis: what's new?
    Singh VK; Moran RA; Afghani E; de-Madaria E
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):901-11. PubMed ID: 25982517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Cavallini G; Frulloni L
    JOP; 2003 Jan; 4(1):75-82. PubMed ID: 12555019
    [No Abstract]   [Full Text] [Related]  

  • 3. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial.
    Yoo KS; Huh KR; Kim YJ; Kim KO; Park CH; Hahn T; Park SH; Kim JH; Park CK; Kwon YJ; Lehman GA
    Pancreas; 2011 Mar; 40(2):181-6. PubMed ID: 21206331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making sense of meta-analyses on the use of protease inhibitors for the prevention of post-ERCP pancreatitis.
    Baron TH; Itoi T
    Gastrointest Endosc; 2011 Apr; 73(4):707-9. PubMed ID: 21457815
    [No Abstract]   [Full Text] [Related]  

  • 5. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproteases in the treatment of acute pancreatitis.
    Kitagawa M; Hayakawa T
    JOP; 2007 Jul; 8(4 Suppl):518-25. PubMed ID: 17625309
    [No Abstract]   [Full Text] [Related]  

  • 7. The Prevention, recognition and treatment of post-ERCP pancreatitis.
    Badalov N; Tenner S; Baillie J
    JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of use of protease inhibitors for the prevention and treatment of pancreatitis after endoscopic retrograde cholangiopancreatography: An epidemiologic analysis of the evidence-practice gap using a health insurance claims database.
    Seta T; Takahashi Y; Yamashita Y; Nakayama T
    Drug Discov Ther; 2019; 13(3):137-144. PubMed ID: 31327789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological management of pancreatitis.
    Hoogerwerf WA
    Curr Opin Pharmacol; 2005 Dec; 5(6):578-82. PubMed ID: 16198632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Sheikh I; Fontenot E; Waghray N; Ismail MK; Tombazzi C; Smith JL
    JOP; 2014 May; 15(3):219-24. PubMed ID: 24865531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Pancreatitis Guideline.
    Crockett S; Falck-Ytter Y; Wani S; Gardner TB
    Gastroenterology; 2018 Mar; 154(4):1102. PubMed ID: 29501369
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kubiliun NM; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2013 Oct; 23(4):769-86. PubMed ID: 24079789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association Institute Technical Review.
    Vege SS; DiMagno MJ; Forsmark CE; Martel M; Barkun AN
    Gastroenterology; 2018 Mar; 154(4):1103-1139. PubMed ID: 29421596
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in Management of Acute Pancreatitis.
    Janisch NH; Gardner TB
    Gastroenterol Clin North Am; 2016 Mar; 45(1):1-8. PubMed ID: 26895677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis.
    Crockett SD; Wani S; Gardner TB; Falck-Ytter Y; Barkun AN;
    Gastroenterology; 2018 Mar; 154(4):1096-1101. PubMed ID: 29409760
    [No Abstract]   [Full Text] [Related]  

  • 18. Protocol-based management strategy for post-endoscopic retrograde cholangiopancreatography pancreatitis: can it make a difference?
    Bhasin DK; Rana SS; Nadkarni N
    J Gastroenterol Hepatol; 2008 Mar; 23(3):344-7. PubMed ID: 18318818
    [No Abstract]   [Full Text] [Related]  

  • 19. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic management and prevention of acute pancreatitis.
    Machicado JD; Papachristou GI
    Curr Opin Gastroenterol; 2019 Sep; 35(5):460-467. PubMed ID: 31205053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.